Zinger Key Points
- The stock is up 5.58% year-to-date but has fallen 27.73% in the past year.
- Investors will be keen to see if Humana can maintain its growth trajectory and how its performance compares to industry peers.
- The new Benzinga Rankings show you exactly how stocks stack up—scoring them across five key factors that matter most to investors. Every day, one stock rises to the top. Which one is leading today?
Health insurance company Humana HUM is set to release its fourth-quarter 2024 earnings report on Feb. 11, before market hours. The stock has dropped 2.37% from the previous close, as of writing, on Feb.10, according to Benzinga Pro.
The stock is up 5.58% year-to-date but has fallen 27.73% in the past year.
In the previous quarter, Humana reported revenues of $29.4 billion — a 15.2% year-over-year increase. It surpassed analysts’ expectations by 2.6%.
The company also achieved a solid beat on earnings per share (EPS) estimates, though it slightly missed full-year EPS guidance estimates.
Also Read: Super Micro Computer Q2 Earnings Preview: Accounting Updates, Nasdaq Deadline On Watch
What To Watch: For the upcoming report, analysts anticipate a 12% year-over-year revenue growth to $28.83 billion. This indicates a deceleration from the 14.7% growth observed in the same quarter last year. An adjusted loss of $2.12 per share is expected.
It’s noteworthy that some of Humana’s peers in the health insurance sector have already reported their Q4 results. Centene CNC delivered a 3.4% year-over-year revenue growth, beating analysts’ expectations by 4.4%, while Cencora COR reported a 12.8% increase, topping estimates by 5.2%.
Investors will be keen to see if Humana can maintain its growth trajectory and how its performance compares to industry peers. Additionally, any updates on operating cost ratios will be closely monitored, especially after the company projected a 30 basis point decrease in its adjusted operating cost ratio for the year during the Q3 earnings call.
Read Next:
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.